Loading...
XSTO
HEART
Market cap6mUSD
, Last price  
SEK
Name

Scandinavian Real Heart AB

Chart & Performance

D1W1MN
XSTO:HEART chart
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
34.03%
Rev. gr., 5y
%
Revenues
0k
-100.00%
1210443226,257148,054132,674774,967111,34700010,0000
Net income
-68m
L+385.97%
-116,791-86,595-13,469-257,530-1,690,217-1,530,513-3,884,081-13,744,106-8,858,271-7,290,240-8,820,671-10,483,500-13,987,911-67,977,292
CFO
-13m
L-48.13%
-1,766,296-1,399,430-3,489,767-9,859,044-6,447,558-7,322,359-9,411,175-9,652,923-7,380,149-25,050,172-12,992,551

Profile

Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.
URL
https://realheart.se/
IPO date
Nov 26, 2014
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10
 
Cost of revenue
50,217
(12,277)
Unusual Expense (Income)
NOPBT
(50,217)
12,287
NOPBT Margin
122,872.70%
Operating Taxes
(67,977)
423
Tax Rate
0.00%
NOPAT
17,760
12,287
Net income
(67,977)
385.97%
(13,988)
33.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
19,585
52,793
345
BB yield
Debt
Debt current
1,897
1,897
621
Long-term debt
4,456
6,353
1,553
Deferred revenue
Other long-term liabilities
Net debt
(17,362)
(35,053)
(9,085)
Cash flow
Cash from operating activities
(12,993)
(25,050)
(7,380)
CAPEX
(25,261)
(1,775)
(23,757)
Cash from investing activities
(24,284)
(1,775)
(23,757)
Cash from financing activities
17,689
58,869
(276)
FCF
161
11,820
17,610
Balance
Cash
23,715
43,303
11,259
Long term investments
Excess cash
23,715
43,303
11,259
Stockholders' equity
10,361
(268,245)
(67,067)
Invested Capital
63,332
358,533
166,768
ROIC
6.76%
7.35%
ROCE
12.32%
EV
Common stock shares outstanding
96,994
49,697
Price
Market cap
EV
EBITDA
(50,062)
12,403
EV/EBITDA
Interest
572
138
Interest/NOPBT
1.12%